• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

体外循环凝血的检测与评分在血液透析中的应用。

Detection and Scoring of Extracorporeal Circuit Clotting During Hemodialysis.

机构信息

Department of Nephrology, Ghent University Hospital, Gent, Belgium.

Department of Nephrology, Ghent University Hospital, Gent, Belgium.

出版信息

Semin Nephrol. 2023 Nov;43(6):151474. doi: 10.1016/j.semnephrol.2023.151474. Epub 2024 Jan 24.

DOI:10.1016/j.semnephrol.2023.151474
PMID:38267348
Abstract

Maintaining patency of the extracorporeal hemodialysis (HD) circuit is a prerequisite to perform HD. Unfractionated heparin and low-molecular-weight heparins are the most used anticoagulants in maintenance HD, but their administration comes with a major trade-off of bleeding complications. This narrative review article discusses technical factors impacting on HD circuit patency, such as tubings, dialyzer membranes, priming practices, and treatment settings. Strategies for monitoring extracorporeal circuit clotting during and after treatment are also reviewed, as these are essential tools for optimizing anticoagulation.

摘要

维持体外血液透析(HD)回路的通畅是进行 HD 的前提条件。普通肝素和低分子量肝素是维持性 HD 中最常用的抗凝剂,但它们的使用带来了出血并发症的主要权衡。本文综述了影响 HD 回路通畅性的技术因素,如管道、透析器膜、预充操作和治疗设置。还回顾了治疗期间和治疗后监测体外回路凝血的策略,因为这些是优化抗凝的重要工具。

相似文献

1
Detection and Scoring of Extracorporeal Circuit Clotting During Hemodialysis.体外循环凝血的检测与评分在血液透析中的应用。
Semin Nephrol. 2023 Nov;43(6):151474. doi: 10.1016/j.semnephrol.2023.151474. Epub 2024 Jan 24.
2
Anticoagulation for people receiving long-term haemodialysis.长期血液透析患者的抗凝治疗。
Cochrane Database Syst Rev. 2024 Jan 8;1(1):CD011858. doi: 10.1002/14651858.CD011858.pub2.
3
Laboratory Monitoring of Heparin Anticoagulation in Hemodialysis: Rationale and Strategies.血液透析中肝素抗凝的实验室监测:原理与策略。
Semin Nephrol. 2023 Nov;43(6):151477. doi: 10.1016/j.semnephrol.2023.151477. Epub 2024 Jan 30.
4
Avoiding Systemic Heparinization During Hemodialysis: How the Dialysis Setup Might Help.避免血液透析过程中的全身肝素化:透析设置如何提供帮助。
Semin Nephrol. 2023 Nov;43(6):151483. doi: 10.1016/j.semnephrol.2023.151483. Epub 2024 Jan 13.
5
Safety of low-molecular-weight heparin compared to unfractionated heparin in hemodialysis: a systematic review and meta-analysis.低分子量肝素与普通肝素在血液透析中的安全性比较:一项系统评价和荟萃分析。
BMC Nephrol. 2017 Jun 7;18(1):187. doi: 10.1186/s12882-017-0596-4.
6
How to Ensure Patency of the Extracorporeal Circuit in Hemodialysis: Global Perspectives.如何确保血液透析体外循环通畅:全球视角。
Semin Nephrol. 2023 Nov;43(6):151476. doi: 10.1016/j.semnephrol.2023.151476. Epub 2024 Jan 24.
7
Regional Citrate Anticoagulation: A Tale of More Than Two Stories.区域性枸橼酸抗凝:一个多故事的传说。
Semin Nephrol. 2023 Nov;43(6):151481. doi: 10.1016/j.semnephrol.2023.151481. Epub 2024 Jan 11.
8
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
9
Non-pharmacological interventions for preventing clotting of extracorporeal circuits during continuous renal replacement therapy.非药物干预措施预防连续性肾脏替代治疗中体外循环凝血。
Cochrane Database Syst Rev. 2021 Sep 14;9(9):CD013330. doi: 10.1002/14651858.CD013330.pub2.
10
Management of urinary stones by experts in stone disease (ESD 2025).结石病专家对尿路结石的管理(2025年结石病专家共识)
Arch Ital Urol Androl. 2025 Jun 30;97(2):14085. doi: 10.4081/aiua.2025.14085.